Read More 3 minute read Penny Stocks SYTA: Siyata Mobile Reports 1st Quarter 2022 Results and Updates the Investor Community on Key Product Categories. By Zacks Small Cap Research Today, 11:16 AM By Thomas Kerr, CFA NASDAQ:SYTA READ THE FULL SYTA RESEARCH REPORT SYTA
Read More 5 minute read Uncategorized RVPH: First Quarter Results By Zacks Small Cap Research Today, 11:16 AM By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT RVPH
Read More 4 minute read Penny Stocks VIRI: Enrollment Complete in FORTRESS Trial; Results Expected in September 2022… By Zacks Small Cap Research Today, 11:16 AM By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT VIRI
Read More 2 minute read Penny Stocks RCRT: Q1 2022 Starts the Year With 117% Revenues Growth and Declining Losses By Zacks Small Cap Research Today, 11:16 AM By Lisa Thompson NASDAQ:RCRT READ THE FULL RCRT RESEARCH REPORT RCRT
Read More 6 minute read Uncategorized ARWR: Phase 3 PALISADE Study of ARO-APOC3 Underway… By Zacks Small Cap Research Today, 11:16 AM By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT ARWR
Read More 2 minute read Uncategorized POET: Could POET’s Biggest Market Be AI Accelerators? By Zacks Small Cap Research Today, 11:16 AM By Lisa Thompson NASDAQ:POET READ THE FULL POET RESEARCH REPORT POET
Read More 3 minute read Uncategorized LGVN: CEO Leaving but Progress Continues By Zacks Small Cap Research Today, 11:16 AM By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT LGVN
Read More 7 minute read Uncategorized ACHV: First Quarter 2022 Results By Zacks Small Cap Research Today, 11:16 AM By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT ACHV
Read More 4 minute read Penny Stocks COCP: Cocrystal Pharma Releases 2022 1st Quarter Results and Provides an Update on the Current Pipeline Programs By Zacks Small Cap Research Today, 11:16 AM By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT COCP
Read More 4 minute read Small Cap OPNT: Positive Results for Pharmacodynamic Trial of OPNT003… By Zacks Small Cap Research Today, 11:16 AM By David Bautz, PhD NASDAQ:OPNT READ THE FULL OPNT RESEARCH REPORT EBS